#
Title
1

Lessons From the Lab: A Patient with Sudden Onset Thigh Pain

2

Lessons From the Lab: Burning feet: A Potpourri of Discussion Around a Seemingly Simple Problem

3

Azathioprine versus Mycophenolate Mofetil, Comparing Effectiveness for Treatment of Generalized Myasthenia Gravis

4

AANEM Guideline on Diagnostic and Screening Tests for Small Fiber Neuropathy

5

Ultrasound-Guided Nerve Hydrodissection for Peripheral Entrapment Neuropathies

6

Webinar: Approach to Immunization in Neuromuscular Disorders

7

AANEM Podcast Featuring ANF: Too Young for ALS? Mikey Stone’s Story and the EMG That Changed Everything

8

Lessons From the Lab: A patient with hand weakness–is a good clinical examination all that you need?

9

Multisystem Proteinopathies

10

Lessons From the Lab: A Patient With Fasciculations Here, There, EVERYWHERE!

11

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 2

12

The Impact of Hormonal Changes During Perimenopause on the Neuromusculoskeletal System - Part 1

13

Monoclonal Gammopathy Associated Myopathies

14

AANEM Crossfire Podcast: Should Neuromuscular Ultrasound be Routinely Used in the Diagnosis of CIDP?

15

Lessons From the Lab: Pediatric EMG Pearls on an Unusual Pediatric Case

16

AANEM Crossfire Podcast: Should Serum Neurofilament Light Chain or NfL be Incorporated into Routine ALS Clinical Practice?

17

AANEM Crossfire Podcast: Should a Combined Sensory Index be Used in Every Case of Suspected Carpal Tunnel Syndrome?

18

Lessons From the Lab: A Numb Foot Could be a Numb-er of Things

19

AANEM Crossfire Podcast: The Balance Between Diagnostic Testing and Clinical Care

20

Lessons From the Lab: LIVE at AANEM – A lively discussion about a strange arm problem.

21

Lessons From the Lab: A woman with shoulder weakness – just a rotator cuff problem?

22

Lessons Learned in the EMG Lab: Elevating EMG Practice Through International Exchange

23

Updates on Neuralgic Amyotrophy

24

Electromyography Referrals Principles and Practices for Optimizing EMG Orders

25

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies: Part 2

26

Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies - Part 1

27

Lessons From the Lab: Progressive Leg Weakness After Running

28

Postural Orthostatic Tachycardia Syndrome (POTS)

29

Lessons From the Lab: Ulnar Neuropathy

30

Global Standardization of EMG and Nerve Conduction Study Training: Challenges and Collaborative Solutions

31

International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Diseases

32

HMGCR Immune-Mediated Necrotizing Myopathy: Review of Clinical Features and Update on Treatment

33

Lessons From the Lab: Breaking Down Atypical Neuropathy

34

Advancing the Field: Perspectives from Nerve Conduction Technologists

35

Training Program Partnership at AANEM

36

Lessons From the Lab: L5 Radiculopathy

37

Lessons From the Lab: Unilateral Tongue Weakness

38

A Discussion About the ADHERE Study: Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod in Patients With CIDP

39

The Evolving Role of Muscle and Nerve Biopsies in Neuromuscular Diagnosis: A Discussion With Experts

40

Understanding the Safety Factor in Neuromuscular Junction Transmission: A Conversation with Dr. Kyle Mahoney

41

Lessons From the Lab: Patient With Trouble Raising Arm: More Than Rotator Cuff?

42

Building Successful Clinical Trial Programs in Neuromuscular Medicine: Insights from Private Practice Experts

43

Lessons From the Lab: A Patient With Poly Neuropathy & Ulnar Neuropathy

44

CIDP in Focus: Evolving Diagnosis, Treatment, and Future Directions - A Discussion with Global Experts

45

Paraproteinemic Neuropathies

46

Advances in the Therapeutic Landscape of Anti-MAG Neuropathy

47

Clinical and Neurophysiological Recovery of Ulnar Nerve Conduction Block at the Elbow

48

Acquired Hyperexcitable Peripheral Nerve Disorders: Clinical and Laboratory Features, Therapeutic Responses, and Long-Term Follow-Up

49

Lessons From the Lab: LIVE 2 Webinar Recording (Aug. 2024)

50

AANEM EDX Lab Accreditation

51

Promoting Quality EDX in Legislation

52

Lessons From the Lab: Approach to a Patient With Weakness

53

Fraud and Abuse

54

Career Phenotypes Part 4 - Perspective from a Clinician in Private Practice

55

Lessons From the Lab: Clinical, EDX, and Practical Approaches for Progressive Weakness

56

Career Phenotypes Part 3 - Perspectives from Neuromuscular Providers on Subspecialty Selection

57

Career Phenotypes Part 2 - Perspective from a Clinician Researcher

58

Career Phenotypes Part 1 - Perspectives from Clinician Educators in Academic Practice

59

Lessons From the Lab: Navigating EDX with Drs. Rubin and Cartwright

60

Comparison of Muscle Ultrasound and Needle Electromyography Findings in Neuromuscular Disorders

61

The Role of AI in NM and EDX Medicine

62

Lessons From the Lab: Peripheral Neuropathy

63

Lessons From the Lab: LIVE Webinar Recording (March 2024)

64

A Discussion of Three Challenging Electrodiagnostic Cases

65

Lessons From the Lab: Electrodiagnostic Assessment of Polyneuropathy

66

Lessons From the Lab: Subacute Lower Extremity Weakness

67

Lessons From the Lab: Evaluation of Patients With Suspected Motor Neuron Disease

68

Diagnosis and Management of Metabolic Myopathies

69

The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy

70

Lessons From the Lab: EMG Discussion with Professor Erik Stalberg

71

Respiratory Considerations in Patients With Neuromuscular Disorders

72

Lessons From the Lab: Scapular Winging

73

ALS Treatment Landscape

74

Lessons From the Lab: A Patient With Bilateral Foot Numbness

75

Lessons From the Lab: EDX & NMUS Approaches to a Patient With Dyspnea

76

Role of Electrodiagnosis in Nerve Transfers for Focal Neuropathies and Brachial Plexopathies

77

Role of Electrodiagnosis in Nerve Transfers for Focal Neuropathies and Brachial Plexopathies

78

Lessons From the Lab: How to Approach Suspected Ulnar Neuropathy in the EMG Laboratory

79

Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

80

Lessons From the Lab: EDX Approach to Radiculopathy

81

Lessons From the Lab

82

Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis, Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) Trials

83

Complement and Neonatal Fc Receptor Inhibitors in Myasthenia Gravis (MG), Highlighting CHAMPION MG (ravulizumab) and ADAPT (efgartigimod) trials

84

Musculoskeletal Mimics of Cervical Radiculopathy

85

Musculoskeletal Mimics of Cervical Radiculopathy

86

Spinal Muscular Atrophy (SMA) and its Management

87

Spinal Muscular Atrophy and its Management

88

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

89

Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis

90

European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force—Second Revision

91

European Academy of Neurology/Peripheral Nerve Society Guideline on Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Report of a Joint Task Force

92

Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

93

Neuromuscular Complications of Immune Checkpoint Inhibitors

94

Neuromuscular Complications of Immune Checkpoint Inhibitors

95

Evaluation of Persons With Suspected Lumbosacral and Cervical Radiculopathy

96

Evaluation of Persons With Suspected Lumbosacral and Cervical Radiculopathy

97

Clinical Features of LRP4/Agrin-Antibody–Positive Myasthenia Gravis

98

Clinical Features of LRP4/agrin-antibody Positive Myasthenia Gravis

99

COVID-19 and Neuromuscular Disorders

100

Approach to Dysphagia With Focus on Neuromuscular Disorders

101

Approach to Dysphagia With Focus on Neuromuscular Disorders

102

Porphyric Neuropathy Part II

103

Porphyric Neuropathy Part I

104

Porphyric Neuropathy Part II

105

Porphyric Neuropathy Part I

106

COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience

107

COVID-19-Associated Guillain-Barre Syndrome: The Early Pandemic Experience

108

Autonomic Neuropathies

109

Autonomic Neuropathies

110

Guidelines on Clinical Presentation and Management of Nondystrophic Myotonias

111

Guidelines on Clinical Presentation and Management of Nondystrophic Myotonias

112

COVID-19 and Neuromuscular Disorders

113

Electrodiagnostic Approach to Patients Presenting With Respiratory Symptoms

114

Anterior Interosseous Nerve Syndrome

115

Rehabilitative Approach to ALS Patients highlighting Eye-Controlled, Power Wheelchair Performs Well for ALS Patients

116

Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part II.

117

Immunomodulatory and Immunosuppressive Therapy for Neuromuscular Disorders Part I

118

Nutritional Neuropathies

119

Quality Improvement Projects in the EMG laboratory

120

Long-term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis

121

Ultrasound-Guided Treatment of Peripheral Entrapment Neuropathies

122

Effect of Shoulder and Elbow Position on Ulnar Nerve Conduction

123

Thymectomy may not be Associated With Clinical Improvement in MuSK Myasthenia Gravis

124

Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis

125

Clinical and Electrodiagnostic Features Of Nontraumatic Sciatic Neuropathy

126

Needle Electromyography and Histopathologic Correlation in Myopathies

127

Muscle Biopsy EMG Correlation

128

Long‐Term Neuromuscular Outcomes of West Nile Virus Infection A Clinical and Electromyographic Evaluation of Patients With a History of Infection

129

Electrodiagnostic Errors Contribute to Chronic Inflammatory Demyelinating Polyneuropathy Misdiagnosis

130

Amyloid TTR Treatment Studies

131

Subcutaneous Versus Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies - A Meta-Analysis

132

Complex and Simple Clinical Reaction Times Are Associated with Gait, Balance, and Major Fall Injury

133

Acute Nutritional Axonal Neuropathy

134

The Value Transformation of Health Care: Impact on Neuromuscular and Electrodiagnostic Medicine

135

Hereditary Myopathies With Early Respiratory Insufficiency in Adults

136

Thoracic Outlet Syndrome Part 1 and Part 2

137

Evaluation of Patients With Refractory Chronic Inflammatory Demyelinating Polyneuropathy

138

International Consensus Guidance for Management of Myasthenia Gravis: Executive Summary

139

Optimizing Muscle Selection for Electromyography in Amyotrophic Lateral Sclerosis

140

Association of Inclusion Body Myositis With T Cell Large Granular Lymphocytic Leukaemia

141

Transthyretin Amyloid Neuropathy has Earlier Neural Involvement but Better Prognosis than Primary

142

POEMS vs CIDP

143

Gene Editing in Monogenic Diseases With CRISPR

144

Presymptomatic ALS Genetic Counseling and Testing: Experience and Recommendations

145

Randomized Trial of Thymectomy in Myasthenia Gravis

146

Normative Data Task Force: Establishing High-Quality Reference Values for NCS

147

Rapid Screening for Inflammatory Neuropathies by Standardized Clinical Criteria

148

Sensory Neuronopathies

149

Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy

150

Critically re-evaluating a common technique: Accuracy, reliability, and confirmation bias of EMG

151

Can Mycophenolate Mofetil be Tapered Safely in MG. A Retrospective, Multicenter Analysis

152

Paraproteinemic Neuropathies

153

Inherited Etiologies of Rhabdomyolysis

154

Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis

155

Clinical Presentation and Acquired Causes of Rhabdomyolysis

156

Patterns of Clinical and Electrodiagnostic Abnormalities in Early Amyotrophic Lateral Sclerosis

157

NCS technique for ulnar neuropathy

158

NCS Technique for Ulnar Neuropathy

159

Neuralgic Amyotrophy (Parsonage-Turner): Etiology, Treatment, Natural History

160

Neuralgic Amyotrophy (Parsonage-Turner): Presentation & Diagnosis

161

Whole Exome Sequencing

162

Next Generation Sequencing and its Impact on Neuromuscular Medicine

163

ALS Onset is Influenced by the Burden of Rare Variants in Known ALS Genes

164

Muscle Intrusion as a Potential Cause of Carpal Tunnel Syndrome

165

Dermatomyositis and Autoantibodies by Dr. Andrew L. Mammen

166

Necrotizing Myopathies by Dr. Andrew L. Mammen

167

Antisynthetase syndrome and myositis by Dr. Andrew L. Mammen

168

Pathokinesiology of Duchenne Muscular Dystrophy

169

Clinical Value of Motor Nerve Conduction Velocity Determination

170

Diagnosis and Treatment of Limb Girdle and Distal Dystrophies, Evidence-Based Guideline

171

Electrodiagnosis of Ulnar Neuropathy at the Elbow (Une): a Bayesian Approach.

172

Myotonic Dystrophy Health Index: Initial Evaluation of a Disease-Specific Outcome Measure

173

Vasculitic Neuropathies

174

Improving Referring Physicians' Understanding of EMG Reports When Qualifying Radiculopathies

175

Exome Sequencing by Michael Shy, MD and Stephan Zuchner, MD

176

Spinal muscular atrophy: Development and Implementation of Potential Treatments

177

Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead by Dr. Blackhall

178

Myasthenia Gravis and the use of IVIg and Therapeutic Plasma Exchange by Dr. Vern Juel

179

Inherited Neuropathies: Clinical Overview and Update by Drs. Christopher Klein and Michael Shy

180

Electrodiagnosis of ulnar neuropathy at the elbow (Une): A bayesian approach

181

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis by Dr.Steven Greenberg

182

Diagnostic Ultrasound of the Fibular (Peroneal) Nerve by Drs. Francis Walker and Michael Cartwright

183

Diagnostic Ultrasound of the Ulnar Nerve and Ulnar Neuropathy at the Elbow by Drs. Francis Walker and Michael Cartwright

184

Diagnostic Ultrasound of the Median Nerve and Median Neuropathy at the Wrist by Drs. Francis Walker and Michael Cartwright

185

Paraneoplastic Neuromuscular Disorders

186

Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies

187

Chronic pain as a manifestation of potassium channel-complex autoimmunity by Dr. Christopher Klein

188

Diagnosis of the Limb-girdle Muscular Dystrophies by Dr. Kate Bushby

189

The Thoracic Outlet Syndromes

190

The Role of Exercise in Amyotrophic Lateral Sclerosis

191

The Distal Hereditary Motor Neuropathies by Dr. Mary Reilly

192

Myokymic and Neuromyotonic Discharges by Drs. Ludwig Gutmann, Jasper Daube, and Devon Rubin

193

Evidence Based Guideline on Treatment of Painful Diabetic Neuropathy by Vera Bril, MD

194

Cardiomyopathies in Muscular Dystrophies by Christopher Spurney, MD

195

Treatment-induced Diabetic Neuropathy: A Reversible Painful Autonomic Neuropathy

196

ALS may be caused by impaired protein recycling and degradation by Teepu Siddique, MD

197

Good Nutritional Control May Prevent Polyneuropathy After Bariatric Surgery by Pariwat Thaisetthawatkul, MD and P. James Dyck, MD

198

Charcot-Marie-Tooth Disease Subtypes and Genetic Testing Strategies by Michael Shy, MD

199

Evaluation and management of foot drop by John D. Stewart, MBBS,MRCP(UK),FRCP

200

A randomized study of alglucosidase alfa in late-onset Pompe's disease by Robert Leshner, MD, and Paula Clemens, MD

201

Post-surgical Inflammatory Neuropathy by P. James B. Dyck, MD and Nathan Staff, MD

202

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

203

A Novel Autoantibody in Patients with Necrotizing Myopathy by Andrew L. Mammen, MD, PhD

204

Pharmacokinetics of IVIg and Outcome in GBS by Krista Kuitwaard, MD

205

A Practical Approach to the Metabolic Myopathies; Diagnosis and treatment: Glycogen Storage Myopathy

206

Practical Approach to the Metabolic Myopathies: Diagnosis and Treatment-FAOD and Mitochondrial Myopathies by Mark A. Tarnopolsky, MD, PhD

207

Genetics, Pathology, and Treatment of Nondystrophic Myotonias by Michael G. Hanna, MD, and Richard J. Barohn, MD

208

Nondystrophic Myotonias by Michael G. Hanna, MD, and Richard J. Barohn, MD

209

Pulsed High-dose Dexamethasone Versus Standard Prednisolone Treatment for CIDP (PREDICT study): a double-blind, randomized, controlled trial by Ivo N. van Schaik, MD, PhD

210

Influenza Vaccination Safety for Patients with Myasthenia Gravis

211

Inclusion Body Myositis

212

Evaluation and Treatment of the Inflammatory Myopathies

213

Toxic, Including Statin, Myopathies

214

Is There an Increased Risk of GBS Following Influenza Vaccines or Other Vaccines?

215

A Discussion about the Distal Symmetric Polyneuropathy Practice Guidelines by John D. England, MD

216

Ascorbic Acid for Charcot–Marie–Tooth Disease by Joshua Burns, PhD

217

Abnormal EMG Findings During Muscle Activation

218

Abnormal Needle EMG Findings with the Muscle at Rest

219

Needle Electromygraphy

220

Needlestick Injuries Among Electromyographers

221

Risk of Hematoma Following Needle EMG Study in Anticoagulated Patients and Patients on Antiplatelet Therapy

222

Stem Cell Replacement Research for ALS

223

Pediatric Electromyography

224

Myofibrillar Myopathies

225

Lessons Learned in Single Fiber EMG

226

Early Days of Single Fiber EMG

227

IgG1 Antibodies to Acetylcholine Receptors in ‘Seronegative’ MG

228

Limb Girdle Muscular Dystrophy

229

Histopathology of Neuropathy

230

Lifetime Course in Myasthenia Gravis

231

Critical Illness Polyneuropathy and Myopathy

232

Sacral Plexopathies

233

Identifying Lumbosacral Radiculopathies

234

Pathokinesiology of Duchenne Muscular Dystrophy

235

Autosomal-Recessive and X-linked Forms of Hereditary Motor and Sensory Neuropathy in Childhood

236

Immunotherapy in Guillain-Barre Syndrome

237

The Therapy of Congenital Myasthenic Syndromes

238

Safety of Nerve Conduction Studies in Patients with Implanted Cardiac Devices

239

Chronic Inflammatory Polyradiculoneuropathy

240

Electromyographic and Magnetic Resonance Imaging to Predict Lumbar Stenosis, Low-back Pain, and No Back Symptoms by Andrew J. Haig, MD

241

Accuracy of Repetitive Nerve Stimulation for Diagnosis of Cramp-Fasciculation Syndrome

242

An Unusual Variant of Acute Idiopathic Polyneuritis

243

The Influence of the Reference Electrode on CMAP Configuration

244

Uremic Neuropathy: Clinical Features and New Pathophysiologic Insights

245

Experimental Allergic Neuritis

246

Sporadic Onset of Erythermalgia

247

Peripheral Neuropathy in Krabbe Disease

248

Radiculopathy and the Herniated Lumbar Disc

249

Sural Neuropathy: Etiologies and Predisposing Factors

250

Is Exercise Necessary with Repetitive Nerve Stimulation in Evaluating Patients with Suspected Myasthenia Gravis

251

Myelin Protein Zero Mutation His39Pro

252

Interferon-Alpha Beta–Mediated Innate Immune Mechanisms in Dermatomyositis

253

Electrophysiological Findings in a Cohort of Old Polio Survivors

254

Clinical Value of Motor Nerve Conduction Velocity Determination

255

Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathies by P. James B. Dyck, MD

256

Rehabilitation Management of Peripheral Neuropathy

257

The Natural History of Primary Lateral Sclerosis

258

Facioscapulahumeral Muscular Dystrophy by Rabi Tawil, MD

259

Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy by Phillip Chance, MD and Mark Hannibal, MD

260

Axillary Pain as a Heralding Sign of Neoplasm Involving the Upper Thoracic Root